MIRM
Mirum Pharmaceuticals, Inc.
Stock
$82.93−0.99 (−1.18%)Close Oct 2, 2026
- Selling, general and administrative, 2025
- $257M
- YoY, 2025
- +27.1%
Selling, general and administrative
Selling, general and administrative by fiscal year
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $257M | +27.1% |
| 2024 | $202M | +38.6% |
| 2023 | $146M | +63.8% |
| 2022 | $89M | +50.4% |
| 2021 | $59M | — |